Ginsenoside Rg1 Attenuates Neuroinflammation in Parkinson's Disease Models via Concomitant Modulation of Canonical and Noncanonical Wnt Pathways in Microglial M1/M2 Polarization.
Ginsenoside Rg1 alleviates neuroinflammation by recalibrating Wnt signals, offering a potential strategy for PD intervention.